checkAd
    Startseite > Aktien > Innoviva > Nachrichten
    Innoviva Aktie
    14,990
     
    USD
    -1,12 %
    -0,170 USD
    Letzter Kurs 02:00:00 Nasdaq
    14,990
     
    USD
    100 STK
    Geldkurs 25.04.24
    15,000
     
    USD
    11.200 STK
    Briefkurs 25.04.24
    ISIN: US45781M1018 · WKN: A2AC9U · SYM: INVA · USA

    Neueste Nachrichten

    Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
    24.04.24 · Business Wire (engl.) · Innoviva
    Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress
    29.02.24 · Business Wire (engl.) · Innoviva
    Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress
    01.11.23 · Business Wire (engl.) · Innoviva
    Innoviva to Participate in the Cantor Global Healthcare Conference
    19.09.23 · Business Wire (engl.) · Innoviva
    XACDURO, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in Adults
    18.09.23 · Business Wire (engl.) · Innoviva
    Innoviva Appoints Stephen Basso as Chief Financial Officer
    25.08.23 · Business Wire (engl.) · Innoviva
    Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
    02.08.23 · Business Wire (engl.) · Innoviva
    Innoviva to Participate in the Goldman Sachs Annual Global Healthcare Conference
    06.06.23 · Business Wire (engl.) · Innoviva
    Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO (sulbactam for injection; durlobactam for injection), Co-packaged for Intravenous Use
    24.05.23 · Business Wire (engl.) · Innoviva
    Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in The Lancet Infectious Diseases
    12.05.23 · Business Wire (engl.) · Innoviva
    Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress
    09.05.23 · Business Wire (engl.) · Innoviva
    Innoviva Announces Retirement of Board Chairman
    28.04.23 · Business Wire (engl.) · Innoviva